Exosomal miR-125b-5p derived from adipose-derived mesenchymal stem cells enhance diabetic hindlimb ischemia repair via targeting alkaline ceramidase 2

Jiahe Guo,Xiaofan Yang,Jing Chen,Cheng Wang,Yue Sun,Chengqi Yan,Sen Ren,Hewei Xiong,Kaituo Xiang,Maojie Zhang,Chengcheng Li,Guoyong Jiang,Xuejiao Xiang,Gui Wan,Tao Jiang,Yu Kang,Xiang Xu,Zhenbing Chen,Wenqing Li
DOI: https://doi.org/10.1186/s12951-023-01954-8
IF: 10.2
2023-06-12
Journal of Nanobiotechnology
Abstract:Ischemic diseases caused by diabetes continue to pose a major health challenge and effective treatments are in high demand. Mesenchymal stem cells (MSCs) derived exosomes have aroused broad attention as a cell-free treatment for ischemic diseases. However, the efficacy of exosomes from adipose-derived mesenchymal stem cells (ADSC-Exos) in treating diabetic lower limb ischemic injury remains unclear.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?